antibodies.cancer.gov antibodies.cancer.gov

antibodies.cancer.gov

The Clinical Proteomic Technologies for Cancer | Antibody Portal

An objective of the Reagents and Resources component of NCI's Clinical Proteomic Technologies for Cancer Initiative is to generate highly characterized monoclonal antibodies to human proteins associated with cancer.

http://antibodies.cancer.gov/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR ANTIBODIES.CANCER.GOV

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

September

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.7 out of 5 with 12 reviews
5 star
8
4 star
4
3 star
0
2 star
0
1 star
0

Hey there! Start your review of antibodies.cancer.gov

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

5.5 seconds

FAVICON PREVIEW

  • antibodies.cancer.gov

    16x16

CONTACTS AT ANTIBODIES.CANCER.GOV

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
The Clinical Proteomic Technologies for Cancer | Antibody Portal | antibodies.cancer.gov Reviews
<META>
DESCRIPTION
An objective of the Reagents and Resources component of NCI's Clinical Proteomic Technologies for Cancer Initiative is to generate highly characterized monoclonal antibodies to human proteins associated with cancer.
<META>
KEYWORDS
1 Antigen
2 Antibody
3 Antigens
4 Antibodies
5 Research
6 NCI
7 National Cancer Institute
8 Proteomic Technologies
9 CPTC
10 cancer
CONTENT
Page content here
KEYWORDS ON
PAGE
skip to content,wwwcancer gov,cptac home,cptac intranet,available antibodies,characterization process,partners,antibody scientific committee,reagent opportunities,antibody portal,print this page,browse by antibodies,browse by antigens,antigen recognition
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

The Clinical Proteomic Technologies for Cancer | Antibody Portal | antibodies.cancer.gov Reviews

https://antibodies.cancer.gov

An objective of the Reagents and Resources component of NCI's Clinical Proteomic Technologies for Cancer Initiative is to generate highly characterized monoclonal antibodies to human proteins associated with cancer.

INTERNAL PAGES

antibodies.cancer.gov antibodies.cancer.gov
1

The Clinical Proteomic Technologies for Cancer | Reagent Opportunities

http://antibodies.cancer.gov/apps/site/reagent_opportunities

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Collaborative Opportunity for Antibody Characterization. More information about the M-CRADA can be found at the following website: http:/ ttc.nci.nih.gov/opportunities/opportunity.php? US Department of Health and Human Services. National Institutes of Health.

2

The Clinical Proteomic Technologies for Cancer | Characterization Process

http://antibodies.cancer.gov/apps/site/characterization_process

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. ELISA is used to assess the direct reactivity of the antibody for the specific antigen." Enzyme Linked ImmunoSorbent Assay (ELISA). IHC is the process of detecting specific proteins in cells of a tissue section by staining protein using labeled antibodies which recognize the specific protein." Immunohistochemistry (IHC). Surface Plamon Resonance (SPR). Protein microarr...

3

The Clinical Proteomic Technologies for Cancer | Antibody Scientific Committee

http://antibodies.cancer.gov/apps/site/antibody_scientific_committee

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. The Antibody Scientific Committee provides scientific insight and guidance to the National Cancer Institute's Antibody Characterization Program. Specifically the members of this committee evaluate request from the external scientific community for development and characterization of antibodies by the program. The members of the Antibody Scientific Committee include:.

4

The Clinical Proteomic Technologies for Cancer | Partners

http://antibodies.cancer.gov/apps/site/partners

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Antibody Characterization Laboratory (SAIC - Frederick, NCI Frederick). Argonne National Laboratories (ANL). Developmental Studies Hybridoma Bank (DSHB) at the University of Iowa. DNASU Plasmid Repository of the Biodesign Institute at Arizona State University (DNASU). Human Protein Atlas (HPA). Ways to Partner with NCI-CPTC Antibody Characterization Program:. Material ...

5

The Clinical Proteomic Technologies for Cancer | About

http://antibodies.cancer.gov/apps/site/about

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Is to facilitate the production, characterization and distribution of these valuable reagents to the global community in order to support protein/peptide measurement and analysis efforts. US Department of Health and Human Services. National Institutes of Health.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

5

LINKS TO THIS WEBSITE

proteomics.cancer.gov proteomics.cancer.gov

SBIR - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/programs/sbir

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Small Business Innovation Research (SBIR). To maximize the initiative's capabilities and impact, CPTC is partnering with the biotechnology industry via the NCI's Small Business Innovation Research (SBIR) Program. A contract mechanism that supports early stage research and development by small businesses. Through the SBIR program, CPTC aims to integrate its efforts ...

proteomics.cancer.gov proteomics.cancer.gov

Programs - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/programs

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. FClinical Proteomic Tumor Analysis Consortium. The National Cancer Institute's (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC). Is composed of three integrated components:. Proteome Characterization Centers (PCCs). Here for more information about CPTAC. Small Business Innovation Research. US Department of Health and Human Services. 160;   National Insti...

proteomics.cancer.gov proteomics.cancer.gov

June 2013 - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/newsevents/eprotein/june2013

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Letter from the Director. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (NCI-CPTAC) has recently begun the proteomic interrogation of genomically-characterized tumors from The Cancer Genome Atlas. Viewing the Targeted Proteomics Horizon with Skyline. Integrating Data with a Focus on Biology. Dialogue on Proteomics in Cancer Research.

proteomics.cancer.gov proteomics.cancer.gov

What is Proteomics? - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/whatisproteomics

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. What is Cancer Proteomics? Refers to the entire complement of proteins, including the modifications made to a particular set of proteins, produced by an organism or a cellular system. This will vary with time and distinct requirements, such as stresses, that a cell or organism undergoes. The term "proteomics". Occur as dictated by the genetic code. In reality, we s...

proteomics.cancer.gov proteomics.cancer.gov

Investigating RAS Signaling in Cancer - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/newsevents/newsannouncements/archive/2014/ras

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Investigating RAS Signaling in Cancer. Posted on December 17, 2014. CPTAC expertise has been charged to develop RAS specific targeted proteomic assays to study the important pathways of human cancer. Assays, reagents and SOPs developed by the awardees will be provided to the public as a community resource to enable studies by cancer researchers in unraveling the oncoge...

proteomics.cancer.gov proteomics.cancer.gov

Video Tutorial - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/whatisproteomics/videotutorial

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Persons with disabilities having problems accessing the above video file may email cancer.proteomics@mail.nih.gov. US Department of Health and Human Services. 160;   National Institutes of Health. 160;   National Cancer Institute. 160;   USA.gov. NIH…Turning Discovery Into Health.

proteomics.cancer.gov proteomics.cancer.gov

Open Data Policy - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/resources/opendatapolicy

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. The Amsterdam Principles: NCI Leads Proteomic Data Sharing Efforts. The Amsterdam Principles include guidelines for the following:. Responsibility for proteomics data release. The Amsterdam Principles White Paper. 2010 Sydney Meeting Extends The Amsterdam Principles. The answers to this question would form “the quality criteria for shared data” and would be...Share the...

proteomics.cancer.gov proteomics.cancer.gov

Events - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/newsevents/events

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. 14th Annual Innovative Molecular Analysis Technologies PI Meeting. November 21, 2013 8:00 AM - November 22, 2013 3:00 PM. The Innovative Molecular Analysis Technologies (IMAT) program was established to support the development, technical maturation, and dissemination of novel and potentially transformative next-generation technologies through an approach of balanced bu...

proteomics.cancer.gov proteomics.cancer.gov

News and Events - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/newsevents

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. August 29, 2016. University of Victoria Genome British Columbia Proteomics Centre Partners with CPTAC. July 19, 2016. New Memorandum of Understanding in Clinical Proteogenomics Between the United States and Australia. July 11, 2016. Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Network. June 29, 2016. May 25, 2016. December 28, 2015.

proteomics.cancer.gov proteomics.cancer.gov

News and Announcements - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/newsevents/newsannouncements

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. News and Announcements RSS. August 29, 2016. University of Victoria Genome British Columbia Proteomics Centre Partners with CPTAC. July 19, 2016. White House Office of the Vice President Announces New Memorandum of Understanding in Clinical Proteogenomics Between the United States and Australia. July 11, 2016. June 29, 2016. May 25, 2016. First Large-Scale Proteogenomi...

UPGRADE TO PREMIUM TO VIEW 104 MORE

TOTAL LINKS TO THIS WEBSITE

114

OTHER SITES

antibodies-online.com antibodies-online.com

ELISA Kits - Antibodies - Research Products

Shipping to United States. No Products on your Comparison List. Your basket is empty. Shipping to North America. 1 404 474 4654. 1 888 205 9894 (Toll-free). Search. Order. Apply. 1,431,966 antibodies, ELISA kits and proteins. More than 140 suppliers. Want additional data for any product? Independent labs will provide it. 1,431,966 Products. An introduction to fluorescence at antibodies-online. BioRiver is a leading network for Biotechnology and Life Sciences experts in the Rhineland bioregion. Alongs...

antibodies-probes.com antibodies-probes.com

Paternity Test and DNA Testing: Want to learn more?

Pricing for Paternity Testing. Parenting Rights of a Biological Father. Prenatal Testing for Paternity. Understanding a Paternity Test Result. Immigration DNA Testing USA. Court Admissible and Legal Paternity Testing. Some Issues and Problems with Paternity Testing. Gender & Prenatal. Genetic Screening in Pregnant Women. Genetic Testing for Diseases in Fetus. Prenatal Testing for Paternity. Screening tests: Ultrasounds & Serum tests. Tom Cruise Paternity Case. Khloe Kardashian’s Paternity. Yes Whilst the...

antibodies-shop.com antibodies-shop.com

Gentaur - antibodies | Targatt | ELISA kits - molecular productsGentaur – antibodies | Targatt | ELISA kits – molecular products

Gentaur – antibodies. Targatt ELISA kits – molecular products. Skip to primary content. Skip to secondary content. March 13, 2013. Gene knock-down using short hairpin RNA (shRNA) to inhibit expression of the corresponding gene has been widely used in gene function studies, drug discovery, and disease research. Our TARGATT Technology allows us to generate in vivo shRNA knock-down mouse models in 3 months. Features of TARGATT shRNA Knock-down Mouse Services:. ShRNA copy number is controlled. Applied Stem C...

antibodies-webshop.com antibodies-webshop.com

GENTAUR!, Your supplier of life science research products

Your supplier of life science research products. Permeabilization solution, 15 mL. DNA staining solution, 5 mL. Anti-quench mounting solution, 5 mL. Would you like to log yourself in. 1910 Kampenhout, Belgium. We offer 100 of different brochures for your projects. You can discuss your custom projects. Show us your results for technical support. We will help you choose your products - You can take them to your lab the same day! We have a lot of free samples available to test. New Products For May. Rapid C...

antibodies.asia antibodies.asia

antibodies.asia

No Content to Display. There is no content to display. Please notify the site administrator or login.

antibodies.cancer.gov antibodies.cancer.gov

The Clinical Proteomic Technologies for Cancer | Antibody Portal

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. NCI 60 Protein Array. Cell Lysate Western Blot. US Department of Health and Human Services. National Institutes of Health.

antibodies.com antibodies.com

Welcome to pachecodeleon.com

antibodies.com.au antibodies.com.au

Antibodies Australia - Home

Welcome to Antibodies Australia! Our mission is to develop an Australian-owned source of high quality antibodies and. Serum products for the Australian and International biotechnological research and industrial. Market at a reasonable price. Phone: 03 9905 8199, email: qun.li@med.monash.edu.au. Online web site design.

antibodies.inasentence.org antibodies.inasentence.org

antibodies in a sentence | simple examples

In A Sentence .org. The best little site that helps you understand word usage with examples. Antibodies in a sentence. Someone announcing P=NP in a non-delicate way is part of Charlie Strosss story. I was going viral this year, but the doctor gave me some. And cleared that right up. Just check how HIV tests are taken , they dont even have virus to compare with, they just count your. It is coded for by DNA - the DNA in each B cell rearrange itself to produce different. This is somewhat like the way. Use a...

antibodies.info antibodies.info

Antibodies.info - the new resource for links and related topics about antibodies

Antibodies.info will be the recourse for links and related topics about antibodies and antibody development. Please come back soon.

antibodies.no antibodies.no

Norwegian Antibodies AS

Moer gard, Kroer. N-1430 Ås, Norway. Phone: 47 64 97 34 00. Welcome to Norwegian Antibodies we customize your chicken antibodies! Norwegian Antibodies delivers high quality chicken antibodies (IgY) customized to your specifications at competitive prices for use in immunoassay methods and products. We manufacture high quality polyclonal chicken antibodies (IgY) for use in diagnostics, biotechnology and life science products. For nearly 2 decades Norwegian Antibodies has specialized in manufacturing of...